Speaker Profile
PhD, Director of the Molecular Epidemiology Laboratory, Wolfson Inst. of Population Health
Biography
As the Director of the Molecular Epidemiology Laboratory, the lead of the MEL research team holds a PhD in genetics from Queen Mary and a Masters from University Pierre et Marie Curie, Paris. With a strong background in functional genomics, this individual also brings commercial insights from a role as Head of Genetics at GeneU, a startup. At Imperial College London, the lead spun out GeneU, focusing on genomics data for skin cancer patient care and patented a concept merging genetics with bioengineering (UK patent GB20110021917). After joining Queen Mary University, the progression was from Senior Research Fellow to Reader by 2022. The primary research focus is on DNA methylation biomarkers for cancer diagnosis and prognosis. Notable achievements include improved methods for papillomavirus infection women triage and the development of a prostate cancer management classifier. Future endeavors aim at early epithelial cancer detection and refining biomarkers across ethnicities.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Laura J. van 't Veer, UCSF
- PMWC 2024 Award Ceremony
Pioneer Honoree: David Sidransky, Johns Hopkins
Pioneer Honoree: Helmy Eltoukhy
Pioneer Honoree: AmirAli Talasaz, Guardant Health - Utilities of Liquid Biopsy in Biomarker Testing
- Laura Vent Veer, UCSF - Status Quo of Clinical Liquid Biopsy (PANEL)
Chair: Helmy Eltoukhy, Guardant Health
- Sadakatsu Ikeda, Tokyo Medical University
- Heather Parsons, Dana-Farber Cancer Institute
- Sanjay Popat, The Royal Marsden - Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
Chair: Anne-Renee Hartman, Adela Bio
- AmirAli Talasaz, Guardant Health
- Heather Parsons, Dana-Farber Cancer Institute
- Mary Pat Lancelotta, Adaptive Bio
- Sylvia Katina Plevritis, Stanford - Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing (PANEL)
Chair: Tom Beer, Exact Sciences
- Wendy Rubinstein, National Cancer Institute
- Sheila D. Walcoff, Goldbug Strategies LLC - Keynote: Pioneering Liquid Nucleic Acids Tumor Fragments in Health and Diseases
- David Sidransky, Johns Hopkins - New Approaches in Liquid Biopsy (PANEL)
Chair: Victor Velculescu, Johns Hopkins
- David Sidransky, Johns Hopkins
- Dan Laudau, NY Genome Center
- Daniel De Carvalho, University of Toronto - Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
Chair: Debra Fraser-Howze, D. Fraser Associates
- Belinda Nedjai, Wolfson Institute of Population Health
- Elisabeth Adams, Aquarius Population Health Limited - NCI Showcase
- Xiaohui Ni, Early Dx
- Daniel Kim, UCSC
